Tarbox Family Office’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-141
Closed -$1K 636
2022
Q1
$1K Hold
141
﹤0.01% 980
2021
Q4
$2K Hold
141
﹤0.01% 898
2021
Q3
$3K Hold
141
﹤0.01% 812
2021
Q2
$4K Hold
141
﹤0.01% 725
2021
Q1
$4K Hold
141
﹤0.01% 652
2020
Q4
$3K Hold
141
﹤0.01% 703
2020
Q3
$4K Hold
141
﹤0.01% 541
2020
Q2
$4K Hold
141
﹤0.01% 534
2020
Q1
$1K Buy
+141
New +$1.28K ﹤0.01% 913

Other funds holding MGNX

Tarbox Family Office's MGNX Position: Q2 2022 in Review

Tarbox Family Office sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 141 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in MGNX in Q1 2020 and held it in 9 quarters. The position peaked at $4K in Q2 2021. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

  • Tarbox Family Office reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 141 MacroGenics shares in Q2 2022, an estimated $1K.
  • Tarbox Family Office first reported a position in MacroGenics in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's MacroGenics position peaked at $4K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.